Regeneron licensed a weight loss drug and revealed study data for a pair of muscle-preserving medicines. Elsewhere, two neuroscience biotechs cut deals and Bluebird officially went private.

One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia ...

The National Institute for Health and Care Excellence is taking more evidence and is expected to announce its decision in the ...

Are you tired of boring dieting and gruesome workouts? Then, medical weight loss treatment can be a solution for you. But ...